Related Experiment Video
Updated: May 28, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
[Mantle cell lymphoma: management in 2011]
C Bonnet1, J Caers, B De Prijck
1Service d'hématologie clinique, Département de médecine interne, CHU Sart-Tilman, Université de Liège, Belgique. cbonnet@ulg.ac.be
Abstract:
Mantle cell lymphoma is a rare form of non Hodgkin lymphomas. Diagnosis is made by demonstrating a typical immunophenotype as well as the presence of a translocation between chromosomes 11 and 14 with overexpression of cyclin D1. First line therapy for young patients consists in 3 cycles of "R-CHOP21" alternated with 3 "R-DHAP21" and followed by an autograft conditioned by total body irradiation, cyclophosphamide and aracytine. For patients over 65 years of age, the treatment of choice consists in 8 cycles of "R-CHOP21". Maintenance treatment is under evaluation. Allografting is the only chance of cure in relapsed patients with good performance status. Targeted therapies will improve the prognosis of this disease.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Myocarditis III: Medical Management
Atherosclerosis III: Management
Myocarditis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
